| 产品名称： | II |
|---|---|
| 商品货号： | TS200979 |
| Designations： | II |
| Species： | Homo sapiens, human |
| Depositors： | JE Sadler |
| Vector： | Construct size (kb): 5.900000095367432 |
| Insert： | DNA: cDNA Insert lengths(kb): 3.200000047683716 Tissue: umbilical vein endothelium cell line Gene product: von Willebrand factor pseudogene VWF Alleles: K2, M1, A4, C1, C2, D1, D2, G1, G2, K1, K2, M1, M1, M2, A1, A2, A3, A5, A6, A7, A4, C1, C2, D1, D2, G1, G2, K1, M1, M2, A1, A2, A3, A5, A6, A7, M2, M2, , , , A1, A2, A1, A1, A2, A2 |
| Insert Size (kb)： | 3.200 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--3.2, 2.7; BamHI--3.9, 1.6; PstI--5.1, 0.56; HindIII--5.9; SacI--4.4, 1.2. Probes I (ATCC 59782/59783), II (TS200979/59785), III (ATCC 59786/59787) and IV (ATCC 59788/59789) constitute non-overlapping fragments of the human von Willebrand factor cDNA sequence that together span essentially the entire 9 kb cDNA. The 1.2 kb BamHI/FspI fragment constitutes probe II and corresponds to amino acids 144-544 of von Willebrand factor. Insert is a 3.2 kb fragment from lambda HvWF4. The 3 1.9 kb of the insert corresponds to vWF sequences. The 5 1.3 kb is an uncharacterized cloning artifact. |
| References： | Shelton-Inloes BB, et al. Evolution of human von Willebrand Factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand Antigen II. Biochem. Biophys. Res. Commun. 144: 657-665, 1987. PubMed: 3495266 Shelton-Inloes BB, et al. Gene deletions correlate with the development of alloantibodies in von Willebrand disease. J. Clin. Invest. 79: 1459-1465, 1987. PubMed: 3033024 J E Sadler, personal communication |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | II |
|---|---|
| 商品货号： | TS200979 |
| Designations： | II |
| Species： | Homo sapiens, human |
| Depositors： | JE Sadler |
| Vector： | Construct size (kb): 5.900000095367432 |
| Insert： | DNA: cDNA Insert lengths(kb): 3.200000047683716 Tissue: umbilical vein endothelium cell line Gene product: von Willebrand factor pseudogene VWF Alleles: K2, M1, A4, C1, C2, D1, D2, G1, G2, K1, K2, M1, M1, M2, A1, A2, A3, A5, A6, A7, A4, C1, C2, D1, D2, G1, G2, K1, M1, M2, A1, A2, A3, A5, A6, A7, M2, M2, , , , A1, A2, A1, A1, A2, A2 |
| Insert Size (kb)： | 3.200 |
| Media： | ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Shipping Information： | Distributed: freeze-dried |
| Comments： | Restriction digests of the clone give the following sizes (kb): EcoRI--3.2, 2.7; BamHI--3.9, 1.6; PstI--5.1, 0.56; HindIII--5.9; SacI--4.4, 1.2. Probes I (ATCC 59782/59783), II (TS200979/59785), III (ATCC 59786/59787) and IV (ATCC 59788/59789) constitute non-overlapping fragments of the human von Willebrand factor cDNA sequence that together span essentially the entire 9 kb cDNA. The 1.2 kb BamHI/FspI fragment constitutes probe II and corresponds to amino acids 144-544 of von Willebrand factor. Insert is a 3.2 kb fragment from lambda HvWF4. The 3 1.9 kb of the insert corresponds to vWF sequences. The 5 1.3 kb is an uncharacterized cloning artifact. |
| References： | Shelton-Inloes BB, et al. Evolution of human von Willebrand Factor: cDNA sequence polymorphisms, repeated domains, and relationship to von Willebrand Antigen II. Biochem. Biophys. Res. Commun. 144: 657-665, 1987. PubMed: 3495266 Shelton-Inloes BB, et al. Gene deletions correlate with the development of alloantibodies in von Willebrand disease. J. Clin. Invest. 79: 1459-1465, 1987. PubMed: 3033024 J E Sadler, personal communication |
